NovaBay Pharmaceuticals, Inc. (NBY)
NYSEAMERICAN: NBY · Real-Time Price · USD
0.5702
0.00 (0.00%)
Apr 25, 2025, 4:00 PM EDT - Market closed

NovaBay Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
33141729
Upgrade
Market Cap Growth
120.45%120.45%-66.44%-76.55%-41.88%63.09%
Upgrade
Enterprise Value
5333816
Upgrade
Last Close Price
0.580.607.1468.25461.34853.83
Upgrade
PS Ratio
0.200.300.130.281.662.93
Upgrade
PB Ratio
-26.15-22.760.400.381.662.36
Upgrade
P/TBV Ratio
--0.980.80-2.36
Upgrade
EV/Sales Ratio
0.470.350.270.200.791.65
Upgrade
Debt / Equity Ratio
-12.96-12.960.790.190.050.04
Upgrade
Asset Turnover
1.571.570.820.710.520.75
Upgrade
Inventory Turnover
5.215.212.111.831.767.22
Upgrade
Quick Ratio
0.290.290.841.722.674.61
Upgrade
Current Ratio
0.680.681.672.663.835.03
Upgrade
Return on Equity (ROE)
-452.75%-452.75%-88.62%-102.37%-51.79%-166.11%
Upgrade
Return on Assets (ROA)
-49.91%-49.91%-20.16%-23.78%-28.25%-30.36%
Upgrade
Return on Capital (ROIC)
-83.23%-83.23%-27.68%-41.17%-47.05%-45.02%
Upgrade
Earnings Yield
-255.17%-245.99%-723.74%-267.27%-34.41%-37.91%
Upgrade
FCF Yield
-159.93%-183.74%-349.33%-170.47%-54.62%-16.30%
Upgrade
Buyback Yield / Dilution
-2730.00%-2730.00%-160.87%-29.11%-24.43%-62.08%
Upgrade
Updated Nov 7, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q